NASDAQ:STAA STAAR Surgical (STAA) Stock Price, News & Analysis $21.92 -0.65 (-2.87%) As of 10:59 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About STAAR Surgical Stock (NASDAQ:STAA) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get STAAR Surgical alerts:Sign Up Key Stats Today's Range$21.89▼$22.6750-Day Range$19.08▼$26.1852-Week Range$15.59▼$35.87Volume160,137 shsAverage Volume1.15 million shsMarket Capitalization$1.10 billionP/E Ratio314.12Dividend YieldN/APrice Target$28.45Consensus RatingHold Company Overview STAAR Surgical is a medical device company focused on ophthalmic surgery and vision correction. The company develops, manufactures and markets implantable lenses and related products designed to reduce or eliminate dependence on glasses or contact lenses. Its principal product line is the EVO Visian Implantable Collamer Lens (ICL), a lens implanted inside the eye to correct myopia, with or without astigmatism. Unlike procedures that remove corneal tissue, ICL surgery preserves the eye’s natural lens and is designed to be removable. STAAR Surgical also offers other ophthalmic lenses and surgical products for refractive and cataract-related procedures, depending on the market. Founded in 1982, STAAR Surgical serves ophthalmic surgeons and patients internationally through direct operations and distribution partners. Its products are marketed across the United States and numerous international markets, including countries in Europe and the Asia-Pacific region. The company is headquartered in Lake Forest, California, and its common stock trades on the Nasdaq under the symbol STAA.AI Generated. May Contain Errors. Read More STAAR Surgical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks71st Percentile Overall ScoreSTAA MarketRank™: STAAR Surgical scored higher than 71% of companies evaluated by MarketBeat, and ranked 188th out of 885 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.0 / 5Analyst RatingHold Consensus RatingSTAAR Surgical has received a consensus rating of Hold. The company's average rating score is 2.08, and is based on no strong buy ratings, 4 buy ratings, 6 hold ratings, and 3 sell ratings.Upside PotentialSTAAR Surgical has a consensus price target of $28.45, representing about 26.1% upside from its current price of $22.57.Amount of Analyst CoverageSTAAR Surgical has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about STAAR Surgical's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth48.72% Earnings GrowthEarnings for STAAR Surgical are expected to grow by 48.72% in the coming year, from $0.39 to $0.58 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of STAAR Surgical is 322.47, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 44.66.Price to Earnings Ratio vs. SectorThe P/E ratio of STAAR Surgical is 322.47, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.34.Price to Book Value per Share RatioSTAAR Surgical has a P/B Ratio of 3.26. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about STAAR Surgical's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted15.37% of the float of STAAR Surgical has been sold short.Short Interest Ratio / Days to CoverSTAAR Surgical has a short interest ratio ("days to cover") of 4.87.Change versus previous monthShort interest in STAAR Surgical has recently increased by 8.64%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSTAAR Surgical does not currently pay a dividend.Dividend GrowthSTAAR Surgical does not have a long track record of dividend growth. News and Social Media2.8 / 5News Sentiment0.46 News SentimentSTAAR Surgical has a news sentiment score of 0.46. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 11 news articles for STAAR Surgical this week, compared to 6 articles on an average week.Search InterestOnly 2 people have searched for STAA on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days.MarketBeat Follows1 people have added STAAR Surgical to their MarketBeat watchlist in the last 30 days. Company Ownership1.4 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, STAAR Surgical insiders have not sold or bought any company stock.Percentage Held by Insiders39.90% of the stock of STAAR Surgical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions96.70% of the stock of STAAR Surgical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about STAAR Surgical's insider trading history. Receive STAA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for STAAR Surgical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. STAA Stock News HeadlinesSTAAR Surgical: A Recovery Story Priced As GrowthOctober 1, 2026 | seekingalpha.comSTAAR Surgical (NASDAQ:STAA) Stock Rating Upgraded by Stifel NicolausOctober 1, 2026 | americanbankingnews.comA weekly dividend fund holding Nvidia and PalantirCrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names distributes income every single Thursday, with payouts reported as high as $1,051 a month. Chief Income Strategist Tim Plaehn breaks down the fund's real Thursday distribution history, how the income is generated, and how to buy it in any brokerage account.October 6 at 1:00 AM | Investors Alley (Ad)STAAR Surgical (NASDAQ:STAA) Shares Up 7.6% on Analyst UpgradeOctober 1, 2026 | americanbankingnews.comWhy Staar Surgical Zoomed Almost 8% Higher on TuesdaySeptember 29, 2026 | fool.comSTAAR Surgical Shares Rise After Stifel UpgradeSeptember 29, 2026 | marketscreener.comMSTAAR Surgical analyst turns bullish on potential for 'meaningful' street upsideSeptember 29, 2026 | msn.comSTAAR Surgical因中國市場增長潛力獲Stifel升評，股價大漲7%September 29, 2026 | hk.finance.yahoo.comSee More Headlines STAA Stock Analysis - Frequently Asked Questions How have STAA shares performed this year? STAAR Surgical's stock was trading at $23.09 at the start of the year. Since then, STAA stock has decreased by 2.3% and is now trading at $22.57. How were STAAR Surgical's earnings last quarter? STAAR Surgical Company (NASDAQ:STAA) issued its earnings results on Wednesday, August, 12th. The medical instruments supplier reported $0.39 EPS for the quarter, topping analysts' consensus estimates of $0.22 by $0.17. The company's revenue for the quarter was up 111.1% on a year-over-year basis. Read the conference call transcript. Is STAAR Surgical buying back stock? STAAR Surgical's Board of Directors approved a stock buyback plan on Thursday, September 24th 2026, which authorizes the company to buy back $50,000,000 in shares, according to EventVestor. This means that the company could reacquire up to 5.2% of its shares through open market purchases. Shares buyback plans are usually a sign that the company's management believes its stock is undervalued. Does STAAR Surgical have any subsidiaries? STAAR Surgical subsidiaries include these companies: Canon Staar, Frigitronics Inc., STAAR Japan Inc., STAAR Optical Equipment, STAAR Surgical AG, STAAR Surgical PTE. LTD, and Technology (Shanghai) Co. LTD. Who are STAAR Surgical's major shareholders? Top institutional investors of STAAR Surgical include Defender Capital LLC. (0.86%). Insiders that own company stock include Broadwood Partners, LP, Aimee S Weisner and Arthur C Butcher. View institutional ownership trends. How do I buy shares of STAAR Surgical? Shares of STAA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of STAAR Surgical own? Based on aggregate information from My MarketBeat watchlists, some other companies that STAAR Surgical investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), Palo Alto Networks (PANW) and JPMorgan Chase & Co. (JPM). Company Calendar Last Earnings8/12/2026Today10/06/2026Next Earnings (Estimated)11/04/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (1m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 STAA's financial health is in the Yellow zone, according to TradeSmith. STAA has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:STAA CIK718937 Webwww.staar.com Phone(626) 303-7902Fax626-303-2962Employees957Year Founded1982Price Target and Rating Average Price Target for STAAR Surgical$28.45 High Price Target$37.00 Low Price Target$13.00 Potential Upside/Downside+29.8%Consensus RatingHold Rating Score (0-4)2.08 Research Coverage13 Analysts Profitability EPS (Trailing Twelve Months)$0.07 Trailing P/E Ratio314.12 Forward P/E Ratio56.21 P/E GrowthN/ANet Income-$80.45 million Net Margins1.13% Pretax Margin5.12% Return on Equity9.05% Return on Assets6.99% Debt Debt-to-Equity RatioN/A Current Ratio4.66 Quick Ratio4.03 Sales & Book Value Annual Sales$339.59 million Price / Sales3.24 Cash FlowN/A Price / Cash FlowN/A Book Value$6.92 per share Price / Book3.17Miscellaneous Outstanding Shares50,144,000Free Float30,137,000Market Cap$1.10 billion OptionableOptionable Beta1.17 Social Links (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (NASDAQ:STAA) was last updated on 10/6/2026 by MarketBeat.com Staff. From Our PartnersThis smart glasses tech is bringing the screen to your eyesGlobal AI smart-glasses shipments surged 263% in the first half of 2026, and Citi projects the market could re...The Tomorrow Investor | SponsoredElon Warns "America Will Go Bankrupt". Trump's Plan Inside.National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...American Hartford Gold | SponsoredFeds Say Your Cash Isn’t Property—Can They Take It?The Department of Justice recently argued in court that cash may not qualify as legal property. That raises...Priority Gold | SponsoredA weekly dividend fund holding Nvidia and PalantirCrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names dist...Investors Alley | SponsoredDo this before December or regret itPorter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monet...Porter & Company | SponsoredThey're not telling you how bad this could getValuations have reached levels seen only a handful of times in the past century, while debt concerns and tarif...Parkview Capital Group | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding STAAR Surgical Company Please log in to your account or sign up in order to add this asset to your watchlist. Share STAAR Surgical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
